Updates
** Hospital operator HCA Healthcare's HCA.N shares fall 5.4% to $322.7
** HCA beat Q1 profit estimates and reiterates 2025 profit forecast as the hospital operator benefited from sustained demand for elective procedures in the United States
** "Company is unclear about the effects of federal policy changes on its business," says CEO Samuel Hazen
** "Company could not give specifics on potential tariff effects, and the market appears to be reacting negatively to that uncertainty despite the strong results that HCA delivered in early 2025," says Morningstar analyst Julie Utterback
** HCA posts Q1 profit of $6.45/share, above analysts' estimate of $5.76/share, according to data compiled by LSEG
** Co maintains its annual profit forecast in range of $24.05-$25.85/share vs est. of $24.92/share
** As of last close, HCA up 13.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。